Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Adam Calaway, MD, MPH

Adam Calaway, MD, MPH

  • Specialty: Urology-Urologic Oncology, Urology
    View Expertise
  • Primary Location: 6681 Ridge Rd (11 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Parma Medical Arts Building 1 (11 mi.)

6681 Ridge Rd
Medical Arts Cntr 1 Ste 411
Parma, OH 44129
440-887-9139

UH Seidman Cancer Center (0 mi.)

11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-5661

University Hospitals (7 mi.)

29001 Cedar Rd
Ste 202
Lyndhurst, OH 44124
216-844-3009

University Hospitals (13 mi.)

9511 W Pleasant Valley Rd
Parma, OH 44130-6002
216-844-3009

Biography: Adam Calaway, MD, MPH

Expertise

  • Urologic Oncology

Titles

  • Co-Director, Robotic Surgery, UH Cleveland Medical Center

Certifications & Memberships

  • Urology - American Board of Urology

Education

Fellowship | Urologic Oncology
Urologic Oncology - Indiana University Hospital (2017 - 2019)

Other Education
Indiana University Purdue University Indianapolis (2017 - 2019)

Residency | Urology
Urology - Indiana University Hospital (2013 - 2017)

Internship | General Surgery
General Surgery - Indiana University Hospital (2012 - 2013)

Medical Education
University Of Toledo College Of Medicine (2012)

Undergraduate
University Of Dayton (2008)

About

Adam Calaway, MD, MPH is board-certified urologist at UH Cleveland Medical Center and an assistant professor of urology at Case Western Reserve University School of Medicine. He joined the medical staff of University Hospitals in 2019.

Dr. Calaway’s unique clinical interests include the management of patients with testicular germ cell tumors and urothelial carcinoma of the bladder. In addition, he has trained extensively in the management of advanced testicular cancer including primary and post-chemotherapy retroperitoneal lymph node dissections. From a research prospective, he is interested in discovering and investigating methods to help reduce treatment-related morbidity in patients diagnosed with urologic malignancies. One of his current projects involves the use of fitness trackers and nutrition counseling to aide in “pre-habilitation” programs to reduce morbidity after bladder removal in patients with advanced bladder cancer.

In his role as assistant professor, Dr. Calaway is involved in bi-weekly educational conferences with the residents which includes case-based discussions, journal article discussions and core urologic oncology topics. He is involved with clinical education in the outpatient clinics and operating rooms with residents as well as prospective medical students. He also mentors residents and medical students interested in urology and specifically urologic oncology. In addition, Dr. Calaway is involved with the cancer care elective where he is paired with second year medical students who are interested in learning about all aspects of oncologic care.

Dr. Calaway graduated summa cum laude from the University of Dayton with a Bachelor of Science in Biology and then completed his medical school education at The University of Toledo College of Medicine where he graduated top of his class. Dr. Calaway completed his general surgery internship and residency at the Indiana University School of Medicine, after which he went on to complete a urologic oncology fellowship. During his fellowship training, he attended The Richard Fairbanks School of Public Health at Indiana University Purdue University Indianapolis where he earned a Masters of Public Health in Epidemiology.

Dr. Calaway has published numerous peer-reviewed articles in high-impact journals such as the Journal of Clinical Oncology, European Urology and Journal of Urology. He has authored 5 book chapters and presented numerous abstracts and participated in multiple debates at regional, national and international meetings. Dr. Calaway actively participates as a peer-reviewer for Journal of Clinical Oncology, Journal of Urology and Journal of the National Comprehensive Cancer Network and Urologic Oncology: Seminars and Original Investigations. In 2019, he was awarded the Star Reviewer award by Urologic Oncology: Seminars and Original Investigations.

Born and raised in Green, Ohio a small suburb between Akron and Canton where his parents still reside, Dr. Calaway returned to Northeast Ohio in 2019 to be closer to his family. He resides here with his wife, whom he met during medical school when they were randomly assigned as anatomy lab partners, and their Labradoodle. He is an avid Cleveland and Ohio State sports fan and can often be seen walking his dog around the various parks in Cleveland or riding his road bike.

Publications

  1. Tachibana I, Calaway AC, Bandali E, Krishnan N, Cheng L, Adra N, Kaimakliotis HK. Urothelial carcinoma in-situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle invasive disease?
  2. Speir RW, Barboza MP, Calaway AC, Masterson TA, Cary C, Koch MO, Birhle R, Cheng L, Adra N, Kaimakliotis HK. Squamous variant histology in urothelial bladder cancer: does presence and percentage matter? In: Clinical Genitourinary Oncology, 2020.
  3. Speir RW, Barboza MP, Boris RS, Calaway AC, Cary C, Foster RS, Masterson TA. Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma. In: Urologic Oncology: Seminars and Original Investigations, 2020.
  4. Boris RS, Calaway AC. Evaluating the impact of minimally invasive vs open trials in urologic malignancy. Are we missing the mark? In: Urologic Oncology: Seminars and Original Investigations, 2020.
  5. Speir RW, Calaway AC, Einhorn LE, Foster RS, Cary C. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HGC levels. In: Urologic Oncology: Seminars and Original Investigations, 2020.
  6. Douglawi A, Calaway AC, Tachibana I, Barboza M, Speir R, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C. Reply by Authors Re: Long-term oncologic outcomes after primary retroperitoneal lymph node dissection: minimizing the need for adjuvant chemotherapy. In: Journal of Urology, 2020.
  7. Douglawi A, Calaway AC, Tachibana I, Barboza M, Speir R, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C. Long-term oncologic outcomes after primary retroperitoneal lymph node dissection: minimizing the need for adjuvant chemotherapy. In: Journal of Urology, 2020.
  8. Mishra, K, Fernstrum A, Mahran A, Sidagam V, Adamic B, Shekar A, Calaway AC. , Nguyen C, Ponsky L and Bukavina L. Epidural Anesthesia is associated with increased complications in Cystectomy Patients: A NSQIP Analysis. In: Urology, 2020.
  9. Calaway AC, Foster RS, Tong Y, Masterson TA, Bihrle R, Cary C. Improving Postoperative Quality of Care in Germ Cell Tumor Patients: Does scheduled Alvimopan, Acetaminophen and Gabapentin Improve Short-Term Clinical Outcomes after Retroperitoneal Lymph Node Dissection? In: Urologic Oncology: Seminars and Original Investigations, 2019.
  10. Abedali Z, Calaway AC, Large T, Koch MO, Lingeman JE, Boris RS. Robot assisted radical prostatectomy in patients with a history of Holmium laser enucleation of the prostate: The Indiana University Experience. In: The Journal of EndoUrology, 2019.
  11. Abedali Z, Calaway AC, Large T, Lingeman JE, Mellon MJ, Boris RS. The Role of PSA Monitoring after Holmium Laser Enucleation of the Prostate (HoLEP). In: Journal of Urology, 2019.
  12. Calaway AC, Einhorn LH, Masterson TA, Foster RS, Cary C. Reply to Gregory J Nason, Michael A.S. Jewitt and Robert J Hamilton’s Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse surgical outcomes associated with robotic retroperitoneal lymph node dissection among patients with testicular cancer. In: European Urology, 2019.
  13. Flack CK, Calaway AC, Miller BL, Picken MM, Gondim DD, Idrees MT, Abel EJ, Gupta GN, Boris RS. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma and chromophobe renal cell carcinoma. In: Urologic Oncology: Seminars and Original Investigations, 2019.
  14. Calaway AC, Einhorn LH, Masterson TA, Foster RS, Cary C. Adverse surgical outcomes associated with robotic retroperitoneal lymph node dissection among patients with testicular cancer. In: European Urology, 2019.
  15. Calaway AC, Tachibana I, Masterson TA, Foster RS, Einhorn LH, Cary C. Oncologic outcomes following surgical management of clinical stage II sex cord stromal tumors. In: Urology, 2019.
  16. Calaway AC, Jacob JM, Tong Y, Shumaker L, Kitley W, Boris RS, Cary C, Kaimakliotis H, Masterson TA, Bihrle R, Koch MO. A prospective program to reduce the clinical incidence of clostridium difficle colitis after cystectomy. In: The Journal of Urology, 2018.
  17. Calaway AC, Foster RS, Adra N, Masterson TA, Albany C, Hanna NH, Einhorn LE, Cary C. Risk of bleomycin related pulmonary toxicities and operative morbidity after post-chemotherapy retroperitoneal lymph node dissection in patients with good risk germ cell tumors. In: Journal of Clinical Oncology, 2018.
  18. Calaway AC, Monn MF, Cary C, Bahler C, Boris R. A novel pre-operative model to predict 90-day surgical mortality in patients being considered for extirpative surgery for renal cell carcinoma. In: Urologic Oncology: Seminars and Original Investigations, 2018.
  19. Calaway AC, Gondim D, Flack CK, Jacob JM, Idrees MT, Boris RS. Anatomic comparison of traditional and enucleation partial nephrectomy specimens. In: Urologic Oncology: Seminars and Original Investigations, 2017.
  20. Snarkis C, Calaway AC, Wang L, Gondim D, Hughes I, Idrees MT, Kliethermes S, Maniar V, Picken MM, Boris RS, Gupta GN. Standardized Reporting of Microscopic Renal Tumor Margins: Introduction of the Renal Tumor Capsule Invasion Scoring System. In: Journal of Urology, 2016.
  21. Calaway AC, Borofsky MS, Dauw CA, Lingeman JE. Getting Out of a PCCL: Percutaneous Cholecystolithotomy as a Salvage Treatment Option for Gallstone Removal in Patients Deemed Unfit for Standard Surgical Approaches. In: The Journal of Endourology Case Reports, 2016.
  22. Monn MF, Jaqua KR, Calaway AC, Mellon MJ, Koch MO, Boris RS. Impact of Obesity on Wound Complications Following Radical Prostatectomy Is Mitigated by Robotic Technique. In: Journal of EndoUrology, 2016.
  23. Calaway AC, Gupta GN, Bhandari A, Eun D, Boris RS. Robot-assisted renal tumor enucleoresection in patients with a solitary kidney. In: The Canadian Journal of Urology, 2014.
  24. Calaway AC, Gondim D, Idrees M, Boris RS. Spontaneous resolution of inflammatory myofibroblastic tumor of the kidney. In: The Canadian Journal of Urology, 2014.
  25. Calaway AC, Whittam B Szymanski KM, Misseri R, Kaefer M, Rink RC, Karymazn B, Cain MP. Multicystic Dysplastic Kidney: Is voiding cystourethrogram necessary? In: The Canadian Journal of Urology, 2014.
  26. Monn, MF, Calaway AC, Mellon MJ, Bahler CD, Sundaram CP, Boris RS. Changing USA national trends for adrenalectomy: the influence of surgeon and technique. In: British Journal of Urology International , 2014.
  27. Whittam BM, Calaway AC, Szymanski KM, Carroll AE, Misseri R, Kaefer M, Rink RC, Boaz K, Cain MP. Ultrasound diagnosis of multicystic dysplastic kidney: Is a confirmatory nuclear medicine scan necessary? In: Journal of Pediatric Urology, 2014.
  28. Sagalovich D, Calaway AC, Srivastava A, Sooriakumaran P, Tewari AK. Assessment of required nodal yield in a high-risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes. In: British Journal of Urology International, 2013.
  29. Sooriakumaran P, Calaway AC, Sagalovich D, Roy S, Srivastava A, Joneja J, Shevchuk M, Tewari AK. The impact of multiple biopsies on outcomes of nerve-sparing robotic-assisted radical prostatectomy. In: International Journal of Impotence Research, 2012.

Featured Videos

Watch to find out more about this University Hospitals provider.

Patient Experience Reviews

4.9 out of 5
- based on 194 Ratings
(5)
10/1/2024

As always, all providers and staff set the gold standard for best in care. I am truly fortunate to have University Hospital and its doctors and staff as my care Team.

(5)
10/1/2024

Dr. Callaway is Wonderful!!!

(5)
10/1/2024

I didn't see a nurse this visit. I saw the Dr,MA,and a person who made my follow-up appointment.

(5)
9/1/2024

Everything was good with all things that were discussed.

(5)
9/1/2024

It was all ok

(5)
9/1/2024

Very prompt, courteous and knowledgable team -- the doctor was very sympathetic to my concerns and answered my many question.

(5)
9/1/2024

Dr. Calaway listened to me and answered my questions.

(5)
9/1/2024

Good experience

(5)
9/1/2024

Very professional and easy to talk to. I preferred working with this specialist rather than the 1 or 2 of the other UH urologists I have seen a while back.

(5)
9/1/2024

All Good! Dr. Calaway is professional and personable.

(5)
9/1/2024

Good

(5)
8/1/2024

THE DOCTOR AND STAFF WERE EXCELLENT.VERY PROFFESSIONAL!

(5)
7/1/2024

Dr. Callaway and his staff are second to none. I would recommend him and his staff to anyone that is in need of very caring MD MPH. He is the best of the best !

(5)
7/1/2024

Very professional and informative

(5)
7/1/2024

Excellent care I have great dr.

(5)
7/1/2024

I am verry pleased with the medical care I was given

(5)
7/1/2024

The entire staff was very helpful and each answered all of my questions very quickly.

(5)
7/1/2024

Dr. Calaway is an outstanding surgeon. I have nothing but admiration for him. ***

(5)
6/1/2024

Dr. Callaway and his staff are excellent providers.

(5)
6/1/2024

Good experience

(5)
5/2/2024

Dr. Calaway is "awesome"!! So were all of his staff!!

(5)
5/1/2024

Dr. Calaway is a urologist, I was not aware I needed to make an appointment with A Nurse Practitioner.

(5)
5/1/2024

Very pleased with Dr. Calaway. This was my first meeting with him. I liked the way he explained all myOptions and illustrated it on paper.

(5)
4/1/2024

Excellent

(5)
4/1/2024

Excellent experience with the office, doctor and nurse.

(5)
4/1/2024

Dr Calloway and his team are very efficient, kind and professional

(5)
4/1/2024

Dr. Calloway is a very good doctor.

(5)
4/1/2024

I was very pleased with my PCP *** and Dr Adam Calaway, they're two of the best in their respective fields of medicine

(5)
4/1/2024

Was very pleased with my experience with the doctor ***

(5)
4/1/2024

Wait time was about a half hour, but overall experience was great, I like University hospital and will continue to attend this hospital

(5)
4/1/2024

He cared about my overall health condition and gave me advice on other problems that I cared about.

(5)
3/1/2024

Amazing experience. Getting diagnosed with cancer obviously isn't a fun experience, but Dr. Callaway was empathetic and explained my prognosis to me in terms I could understand. I was very impressed by how In-depth his explanation was and how he made It easy to understand. I have full confidence in him as my surgeon. I'm very appreciative that he made my care a true priority.

(5)
3/1/2024

Everyone, from start to finish [...] Best specialist visit we have ever had through UH!

(5)
3/1/2024

Absolutely amazing care. So very glad I am working with them.

(5)
3/1/2024

This was my first tine with Dr. Calaway. He was very attentive. But he told me I only need to see a Nurse Practitioner.

(5)
3/1/2024

Very good care as usual!

(5)
2/1/2024

Nurse after visit was awesome

(5)
1/1/2024

Excellent care and concern for me, thank you!

(5)
1/1/2024

Dr Calaway Is such a pleasure. I always say that University Hospitals Is very patient oriented and Dr. Calaway Is certainly that.

(5)
1/1/2024

First visit, very professional and informative.

(5)
1/1/2024

Very good

(5)
12/1/2023

Everything about this office is top notch. Wonderful doctor, staff, receptionist and nurses. I have been to this office several times and I was elated to see it was so clean and orderly. You don't find those offices like that anymore. It was a wonderful experience to been seen by Dr. Callaway. I highly recommend him (Dr. Callaway) and his facility.

(5)
12/1/2023

Always goes over what I should expect with my condition.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Adam Calaway did not disclose any Outside Relationships with Industry.